Tag: Iveric bio

October 28, 2019 Off

Iverics’ bio’s Zimura meet primary endpoint in Phase 2b Trial in certain Macular Degeneration

By BusinessWire

Iverics’ bio’s Zimura meet primary endpoint in Phase 2b Trial in certain Macular Degeneration, as overall data suggest a dose…

IVERIC bio, Catalent’s Paragon Gene Therapy in deal for Orphan Inherited Retinal Diseases

June 17, 2019 Off

IVERIC bio, Catalent’s Paragon Gene Therapy in deal for Orphan Inherited Retinal Diseases

By BusinessWire

NEW YORK & SOMERSET, N.J.–(BUSINESS WIRE)–IVERIC bio, Inc. (NASDAQ: ISEE) and Catalent Biologics, today announced that they have entered into…